MANAGEMENT OF THYROID CARCINOMA: HAHNEMANN EXPERIENCE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

DADPARVAR S.; LAHANIATIS J.E.; ASRARI F.; SHAIKH A.A.; GHESANI N.V.; TULCHINSK M.; PAN M.; SLIZOFSKI W.J.; BRADY L.W.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: IRANIAN JOURNAL OF NUCLEAR MEDICINE Year:2001 | Volume:- | Issue:14-15 Page(s): 26-29

Download Full-Text

View:

287

Download:

Cites:

Information Journal Paper

Title

MANAGEMENT OF THYROID CARCINOMA: HAHNEMANN EXPERIENCE

Author(s)

Keywords

Not Registered.

Abstract

The primary treatment of thyroid carcinoma is surgery and the outcome depends on its extent. The post-operative management alternatives in thyroid carcinoma include thyroid hormone, radio-iodine ablation (1-131Na), external beam radiation therapy (EBRT) and occasionally adjuvant chemotherapy. This retrospective study analyzes the managements of 153patients (102 , 51 ), age range 10-96years, mean age 50.2 years treated for thyroid carcinoma. The range of follow-up was 1.0-294months with median follow-up for 60.4 months. Twenty patients without therapy were excluded. Group A included 87 patients treated with 1-131. Group B consisted of 13 patients received EBRT. Group C included both therapies in 33 patients. The therapies in all different stages of thyroid carcinoma and with various histopathology’s were reviewed. Stage I Stage II Stage III Stage IV Group A: = 87 12 29 34 12 Group B: = 13 0 0 2 11 Group C: = 33 0 0 14 19 The 1-131 Na therapy was applied in all stages of thyroid carcinoma, but the need for EBRT or

Cites

No record.

References

No record.

Cite

APA: Copy

DADPARVAR, S., LAHANIATIS, J.E., ASRARI, F., SHAIKH, A.A., GHESANI, N.V., TULCHINSK, M., PAN, M., SLIZOFSKI, W.J., & BRADY, L.W.. (2001). MANAGEMENT OF THYROID CARCINOMA: HAHNEMANN EXPERIENCE. IRANIAN JOURNAL OF NUCLEAR MEDICINE, -(14-15), 26-29. SID. https://sid.ir/paper/545618/en

Vancouver: Copy

DADPARVAR S., LAHANIATIS J.E., ASRARI F., SHAIKH A.A., GHESANI N.V., TULCHINSK M., PAN M., SLIZOFSKI W.J., BRADY L.W.. MANAGEMENT OF THYROID CARCINOMA: HAHNEMANN EXPERIENCE. IRANIAN JOURNAL OF NUCLEAR MEDICINE[Internet]. 2001;-(14-15):26-29. Available from: https://sid.ir/paper/545618/en

IEEE: Copy

S. DADPARVAR, J.E. LAHANIATIS, F. ASRARI, A.A. SHAIKH, N.V. GHESANI, M. TULCHINSK, M. PAN, W.J. SLIZOFSKI, and L.W. BRADY, “MANAGEMENT OF THYROID CARCINOMA: HAHNEMANN EXPERIENCE,” IRANIAN JOURNAL OF NUCLEAR MEDICINE, vol. -, no. 14-15, pp. 26–29, 2001, [Online]. Available: https://sid.ir/paper/545618/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops